×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

PROGRAMME:

Modérateurs: Fabrice Lécuru et Manuel Rodrigues
19:00
Spécificités des soins de support en ovaire : gestion de la carcinose symptomatique et pré-habilitation en néoadjuvant
Carole Bouleuc
 
 
19:15
Quel avenir à l’immunothérapie dans les cancers de l’ovaire ?
Audrey Bellesoeur
 
19:30
Traitement des récidives sous PARPi
Manuel Rodrigues
 
19:45
Chirurgie de la récidive : au-delà des essais GOG213, SOC1 & DESKTOP
Fabrice Lécuru
 
 
20:00
Débat/Discussion - Réponses aux questions
 
 
  
Shooting date : 2022-03-22
Last update : 2022-03-24
1 comment
Join the Discussion
  • johanne L. bonjour comment fait-on pour s inscrire ?

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Wednesday, November 10th 2021 from 06pm to 07:30pm (GMT+1)
    Honolulu : Wednesday, November 10th 2021 from 07am to 08:30am (GMT+1)
    San Francisco : Wednesday, November 10th 2021 from 09am to 10:30am (GMT+1)
    New York : Wednesday, November 10th 2021 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Wednesday, November 10th 2021 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Wednesday, November 10th 2021 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Wednesday, November 10th 2021 from 06pm to 07:30pm (GMT+1)
    Istanbul : Wednesday, November 10th 2021 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Wednesday, November 10th 2021 from 09pm to 10:30pm (GMT+1)
    Bangkok : Thursday, November 11th 2021 from 12am to 01:30am (GMT+1)
    Shanghai : Thursday, November 11th 2021 from 01am to 02:30am (GMT+1)
    Tokyo : Thursday, November 11th 2021 from 02am to 03:30am (GMT+1)
    Sydney : Thursday, November 11th 2021 from 03am to 04:30am (GMT+1)
    Wellington : Thursday, November 11th 2021 from 05am to 06:30am (GMT+1)

    La prise en compte de la qualité de vie, des choix des patientes en cancérologie gynécologique

    Comment passer des recommandations de Saint-Paul-de-Vence à la pratique quotidienne ?

    Share
    0
    Days
    0
    Hours
    0
    Minutes
    0
    Seconds
    Wednesday, January 22nd 2025 from 06pm to 07:30pm (GMT+1)
    Honolulu : Wednesday, January 22nd 2025 from 07am to 08:30am (GMT+1)
    San Francisco : Wednesday, January 22nd 2025 from 09am to 10:30am (GMT+1)
    New York : Wednesday, January 22nd 2025 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Wednesday, January 22nd 2025 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Wednesday, January 22nd 2025 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Wednesday, January 22nd 2025 from 06pm to 07:30pm (GMT+1)
    Istanbul : Wednesday, January 22nd 2025 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Wednesday, January 22nd 2025 from 09pm to 10:30pm (GMT+1)
    Bangkok : Thursday, January 23rd 2025 from 12am to 01:30am (GMT+1)
    Shanghai : Thursday, January 23rd 2025 from 01am to 02:30am (GMT+1)
    Tokyo : Thursday, January 23rd 2025 from 02am to 03:30am (GMT+1)
    Sydney : Thursday, January 23rd 2025 from 03am to 04:30am (GMT+1)
    Wellington : Thursday, January 23rd 2025 from 05am to 06:30am (GMT+1)

    Prise en charge des cancers de l'ovaire en rechute :

    état des lieux et perspectives

    Tuesday, October 11th 2022 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, October 11th 2022 from 07am to 08:30am (GMT+2)
    San Francisco : Tuesday, October 11th 2022 from 10am to 11:30am (GMT+2)
    New York : Tuesday, October 11th 2022 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Tuesday, October 11th 2022 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Tuesday, October 11th 2022 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Tuesday, October 11th 2022 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Tuesday, October 11th 2022 from 07pm to 08:30pm (GMT+2)
    Istanbul : Tuesday, October 11th 2022 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, October 11th 2022 from 09pm to 10:30pm (GMT+2)
    Bangkok : Wednesday, October 12th 2022 from 12am to 01:30am (GMT+2)
    Shanghai : Wednesday, October 12th 2022 from 01am to 02:30am (GMT+2)
    Tokyo : Wednesday, October 12th 2022 from 02am to 03:30am (GMT+2)
    Sydney : Wednesday, October 12th 2022 from 04am to 05:30am (GMT+2)
    Wellington : Wednesday, October 12th 2022 from 06am to 07:30am (GMT+2)

    Cancer de l’ovaire

    Share
    Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, January 31st 2023 from 07am to 08:30am (GMT+1)
    San Francisco : Tuesday, January 31st 2023 from 09am to 10:30am (GMT+1)
    New York : Tuesday, January 31st 2023 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Tuesday, January 31st 2023 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Tuesday, January 31st 2023 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
    Istanbul : Tuesday, January 31st 2023 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, January 31st 2023 from 09pm to 10:30pm (GMT+1)
    Bangkok : Wednesday, February 1st 2023 from 12am to 01:30am (GMT+1)
    Shanghai : Wednesday, February 1st 2023 from 01am to 02:30am (GMT+1)
    Tokyo : Wednesday, February 1st 2023 from 02am to 03:30am (GMT+1)
    Sydney : Wednesday, February 1st 2023 from 03am to 04:30am (GMT+1)
    Wellington : Wednesday, February 1st 2023 from 05am to 06:30am (GMT+1)

    Cancer de l'ovaire en 1L :

    Actualités et options thérapeutiques disponibles en 2023

    Share
    Scroll Up